ATXI · Forms 3, 4, 5
Insider trades at AVENUE THERAPEUTICS, INC.
No open-market insider buys or sells at AVENUE THERAPEUTICS, INC. in the last 90 days; 5 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for AVENUE THERAPEUTICS, INC. (ATXI) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for AVENUE THERAPEUTICS, INC. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 10% owner | Award | 111,209 | Form 4 | |||
| Fortress Biotech, Inc. | 10% owner | Award | 33,724 | Form 4 | |||
| Fortress Biotech, Inc. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Neil Herskowitz | Director | Sell | 23 | $2.00 | $46 | Form 4 | |
| Jay D Kranzler | Director | Sell | 61 | $2.24 | $137 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.